Long persistence of tumour necrosis factor-α antagonist-induced autoantibodies under subsequent treatment with ustekinumab but no adverse effects: a case study of 14 patients with psoriasis.
Br J Dermatol
; 178(1): e9-e10, 2018 01.
Article
em En
| MEDLINE
| ID: mdl-28581119
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Psoríase
/
Anticorpos Antinucleares
/
Fator de Necrose Tumoral alfa
/
Fármacos Dermatológicos
/
Ustekinumab
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article